# Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

> **NCT00351962** · NA · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 58 (actual)

## Conditions studied

- Lung Neoplasms
- Lung Cancer

## Interventions

- **PROCEDURE:** Fractionated Stereotactic Radiotherapy

## Key facts

- **NCT ID:** NCT00351962
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-07-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351962, "Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00351962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*